EN DE
Watch Collaxio B for free: we tell you when fair value or trend changes.
Data-driven stock valuation

Collaxio B (COLLAX) fair value: what the stock is really worth

As of Nov 6, 2026: fair value (intrinsic value) of Collaxio B stock SEK 0.68, price SEK 0.40, upside +70.0%, quality 38 out of 100. Rating: strongly undervalued. Calculated from audited financials with 2 of our 26 valuation models and 37 quality factors, updated daily.

  1. Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free

Financial Services SE

CB Collaxio B logo Thin data Nov 7, 2026

Collaxio B

COLLAX · ST
Cheap, value-trap risk

The stock costs 41% less than our calculation considers fair.

Fair value kr 0.6766 · Strongly undervalued
Even on cautious assumptions the value is 27% above the price (kr 0.5058).
Quality 38/100
Weak Growth (revenue YoY −72.2 %/yr in SEK)
Negative free cash flow
Trails peers (1/6)
Narrow moat 10/100 · thin data
Thin data
⚠ Dilution
Watch Collaxio B for free: we tell you when fair value or trend changes. Watch for free

What runs behind every stock

26 valuation models 8 families, DCF to NCAV 37 quality factors margins, balance sheet, cashflow, debt 6 AI factors moat, what no ratio measures 2,000+ data points verified, per stock, median

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

kr 1.12 kr 0.3800 Fair Value kr 0.6766 Oct 2025 Nov 2026

White line = price, green steps = our fair value per fiscal year. As of Nov 7, 2026.

How to read this chart

12‑month range kr 0.3800 – kr 1.12 · fair‑value band kr 0.5058 – kr 0.8475 · the kr 0.3980 price screens below the kr 0.6766 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). As of Nov 7, 2026.

Follow Collaxio B in your weekly email

Every Wednesday you see whether Collaxio B is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Collaxio AB (publ) is a private equity, venture capital and secondary (direct) firm specializing in acquisitions & buy-and-build investments. It prefers to invest in four key sectors-B2B/SaaS & platform solutions, quality of life, transformational shifts and opportunistic.

Show moreShow less

It prefers to have a board representation and advisory board seats in its portfolio companies. Collaxio AB (publ) was founded in 2025 and is based in Stockholm, Sweden with additional offices in Shanghai, China.

Stock analysis

Collaxio B (COLLAX) currently trades at kr 0.3980, while our model-based Fair Value estimate is kr 0.6766, implying the stock looks roughly 41% undervalued today.

Show more

Valuation

How firm this estimate is: it rests on 2 models at a data quality of 92/100, which puts the data coverage at low.

Scenario range: kr 0.5058 (bear) to kr 0.8475 (bull), the price of kr 0.3980 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 38/100 (below-average quality), in the Financial Services sector.

Weak Growth: Revenue growth is weak, negative or inconsistent.

Collaxio B reported revenue of 944K SEK in FY2025 versus −23.0M SEK in FY2022. Reported net income was −35.4M SEK in FY2025.

Key figures

Market cap 34.6M SEK (≈ $3.5M) Micro · EPS (TTM) kr −0.2500 · Return on equity −16.1% · Return on assets (EBIT) −28.9% (4-year average) · Operating margin −380% · Revenue (TTM) −16.0K SEK · Free cash flow −15.3M SEK.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 10 out of 100 (low confidence).

What moves the price

The share trades about 64% below its 52-week high and 5% above its 52-week low, currently below its 200-day average.

For context, the median of 10 Financial Services peers we cover trades at −16% fair-value upside, at 70%, COLLAX screens cheaper than that median.

Fair Value models

Bear kr 0.5058 Fair Value kr 0.6766 Bull kr 0.8475
Price kr 0.3980 · Upside +70.0%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above starts from their evidence-weighted blend, not from a single model. In cyclical trough or peak years, after dilution or a stock split it is adjusted afterwards, so it can sit above or below the models. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds. Coverage ⓘCoverage = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Best data coverage
P/B Multiple kr 0.6500 kr 0.8700 kr 1.09 55
NCAV (Graham) kr 0.1900 kr 0.2800 kr 0.3500 52
All 2 models by family
Multiples
P/B Multiple kr 0.6500 kr 0.8700 kr 1.09 55
Asset-Based
NCAV (Graham) kr 0.1900 kr 0.2800 kr 0.3500 52

The fair value above starts from this blend and is adjusted for dilution from new shares.

Open the full fair value analysis →

Quality Score breakdown

Overall quality 38/100

It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.

Profitability 0
How much profit the company makes from its sales and capital
Quality Growth 8
Are margins and returns getting better?
Cashflow 25
Do the profits arrive as real cash?
Financial strength 100
Debt, balance sheet and risk of trouble
Investment 100
Does it invest with discipline instead of growing at any price?
Low Volatility 47
How calm the share price moves, does not count
Price momentum 12
Price momentum of the last 3 to 12 months, does not count
Near the 52-week high 1
Distance to the 52-week high, does not count
New shares 0
Buys back shares or issues new ones?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 0/100
Revenue growth is weak, negative or inconsistent.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed

Watch COLLAX, get fair value alerts →

Compare Collaxio B with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Asset Management · 587 stocks

Beats the industry median on 1/5 measures
Overall it trails its industry peers.
Valuation
Quality Score 38 · Bottom 25%
Fair Value upside +70.0% · Above median
Profitability
Return on assets −34.5% · Bottom 25%
Growth and dividend
Revenue growth (quarter YoY) 0.0% · Below median
Dividend yield (12 months) 0.0% · Bottom 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)100 · sector 60
FUTURE (revenue growth)0 · sector 38
PAST (return on equity)0 · sector 29
HEALTH (low debt)0 · sector 96
DIVIDEND (yield)0 · sector 80

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Asset Management stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value Compare
Exor N.V EXO €73.35 €139.37 +90% vs COLLAX
Raymond James Financial, Inc RJF $162.81 $281.42 +73% vs COLLAX
Apollo Global Management, Inc APO $116.75 $197.52 +69% vs COLLAX
Ameriprise Financial, Inc AMP $501.49 $609.56 +22% vs COLLAX
State Street Corporation STT $165.56 $139.37 −16% vs COLLAX
Ares Management Corporation ARES $133.98 $99.35 −26% vs COLLAX
Northern Trust Corporation NTRS $172.76 $123.42 −29% vs COLLAX
Brookfield Asset Management Ltd BAM $52.95 $31.26 −41% vs COLLAX
Blackstone Inc BX $119.50 $52.29 −56% vs COLLAX
KKR & Co KKR $96.48 $27.32 −72% vs COLLAX

Explore undervalued stocks

More undervalued Financial Services stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend StocksUndervalued 52-Week Low Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

Stock screenerFilter by region, size and sector Compare toolTwo stocks side by side Extrinsic Value Calculator…Free calculator Peter Lynch Fair Value Formula &…Free calculator
Run the numbers yourself: free valuation calculators
DCF CalculatorP/E Ratio CalculatorPEG Ratio CalculatorGraham NumberPeter Lynch FormulaDDM CalculatorIntrinsic ValueIntrinsic vs Extrinsic ValueP/E Ratio by Sector
For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Collaxio B: fair value per Fair Value Calculator

Cite: Fair Value Calculator (2026). "Collaxio B Fair Value". https://www.fairvalue-calculator.com/stock/COLLAX

Frequently asked questions

Is Collaxio B (COLLAX) overvalued or undervalued?
As of Nov 7, 2026, our model estimates a fair value of kr 0.6766 versus a price of kr 0.3980, about +70% upside (undervalued).
What is the fair value of COLLAX?
Our model-based fair value for Collaxio B is kr 0.6766 (as of Nov 7, 2026), built from audited fundamentals. The current price: kr 0.3980.
What is the quality score of COLLAX?
Collaxio B has a Quality Score of 38/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Collaxio B (COLLAX)?
Our model-based price target is the fair value of kr 0.6766 (as of Nov 7, 2026) from 2 valuation models. Cautious scenario kr 0.5058, optimistic scenario kr 0.8475. It is a calculation from audited fundamentals, not an analyst target.
What is the Collaxio B stock forecast for 2026?
Our models put fair value at kr 0.6766, about +70% upside versus a price of kr 0.3980 (undervalued). Cautious scenario kr 0.5058, optimistic scenario kr 0.8475. The calculation is refreshed regularly with new filings.
What is the intrinsic value of Collaxio B (COLLAX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Collaxio B it is kr 0.6766 per share (as of Nov 7, 2026), against a price of kr 0.3980. It is the blended result of 2 valuation models in 2 families (Multiples, Asset-Based).
Is Collaxio B stock overvalued or undervalued in 2026?
As of Nov 7, 2026, COLLAX trades below its calculated fair value: price kr 0.3980, fair value kr 0.6766, a gap of about +70% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of COLLAX?
No. The price is what the market pays today (kr 0.3980); the fair value is what the company's own numbers justify (kr 0.6766). For Collaxio B the two are kr 0.2786 per share apart. That gap is exactly why we show both numbers side by side.
How much is Collaxio B worth?
The market values Collaxio B at about 34.6M SEK (market capitalisation, as of Nov 7, 2026). Per share that is kr 0.3980; our models calculate a fair value of kr 0.6766 per share.
What do the bullish and bearish scenarios say about COLLAX?
Our models span a range for Collaxio B: cautious scenario kr 0.5058, base kr 0.6766, optimistic kr 0.8475 per share (as of Nov 7, 2026, price kr 0.3980). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Collaxio B (COLLAX)?
Balance-sheet figures for Collaxio B (as of Nov 7, 2026): return on equity −16.1%. They feed the Quality Score of 38/100, which measures business quality independently of the share price.
How far is COLLAX from its 52-week high?
Collaxio B trades at kr 0.3980, about 64% below its 52-week high of kr 1.12 and 5% above the low of kr 0.3800 (as of Nov 6, 2026). Distance from the high says nothing about value: that is what the fair value of kr 0.6766 is for.
Which stocks are comparable to Collaxio B?
From the same area (Financial Services) we also value Blackstone Inc, Brookfield Asset Management Ltd, KKR & Co, Apollo Global Management, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Collaxio B stock attractive at the current price?
The data as of Nov 7, 2026: price kr 0.3980, calculated fair value kr 0.6766 (+70%), Quality Score 38/100, from 2 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of COLLAX calculated?
We run Collaxio B through 2 models from 2 families: Multiples, Asset-Based. Every model gets the same audited fundamentals; the fair value of kr 0.6766 builds on their evidence-weighted average, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.3% above its aggregate fair value. Collaxio B currently trades 41% below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Collaxio B (COLLAX)?
The closing price on Nov 6, 2026 was kr 0.3980. Our model-based fair value is kr 0.6766, about +70% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Collaxio B right now?
The large discount to fair value meets weak quality (38/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (kr 0.5058). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.

Key figures of Collaxio B

How large is the market capitalisation of Collaxio B (COLLAX)?
The market capitalisation of Collaxio B is 34.6M SEK (≈ $3.5M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What are the earnings per share of Collaxio B (COLLAX)?
Earnings per share at Collaxio B are kr −0.2500. Earnings per share over the last twelve months: total profit spread across every single share.
What is the return on equity of Collaxio B (COLLAX)?
The return on equity (ROE) of Collaxio B is −16.1% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Collaxio B (COLLAX)?
On an EBIT basis the return on assets of Collaxio B is −28.9% (avg 4y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Collaxio B (COLLAX)?
The operating margin of Collaxio B is −380% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How much revenue does Collaxio B (COLLAX) generate?
Collaxio B generates revenue of −16.0K SEK (last twelve months). Revenue of the last twelve months (TTM), the most recent full year, not the calendar year.
How much free cash flow does Collaxio B (COLLAX) generate?
The free cash flow of Collaxio B is −15.3M SEK (fiscal year 2025). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
Free · no account needed

Watch Collaxio B in the live analysis

One click puts Collaxio B on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.